MarketResearch.com logo

Recent Drug Discovery Research for November 2024


Sarcopenia (Musculoskeletal) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Women's Health, Obstetrics/Gynecology
Chemotherapy Induced Nausea and Vomiting (Other Diseases) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery
Chemotherapy Induced Neutropenia (Other Diseases) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery
Opioid-Induced Constipation (OIC) (Other Diseases) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gastrointestinal
Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021
Topics: Drug Development, Arthritis, Drug Discovery, Allergy/Immunology, Rheumatology/Arthritis
Beta Nerve Growth Factor (Beta NGF or NGF) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Transforming Growth Factor Beta 1 (TGFB1) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Toll Like Receptor 8 (CD288 or TLR8) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
Systemic Sclerosis (Scleroderma) - Epidemiology Forecast to 2030
Topics: Autoimmune, Drug Discovery
Global Nitrocellulose Membranes Industry Research Report Growth Trends and Competitive Analysis 2021-2027
Topics: Membranes & Separations, Manufacturing, Packaging & Detailing, Drug Discovery
Regions: Global
Dyslipidemia - Competitive Landscape in 2021
Topics: Heart Health, Drug Discovery, Cardiovascular
Uveitis - Global Drug Forecast and Market Analysis to 2029
Topics: Autoimmune, Drug Discovery
Regions: Global
Pressure Ulcers (Dermatology) - Drugs In Development, 2021
Topics: Drug Discovery, Dermatology
Nasal Polyps (Nasal Polyposis) (Ear Nose Throat Disorders) - Drugs In Development, 2021
Topics: Drug Discovery
Crigler-Najjar Syndrome (Genitourinary Disorders) - Drugs In Development, 2021
Topics: Drug Discovery
Familial Adenomatous Polyposis (Genitourinary Disorders) - Drugs In Development, 2021
Topics: Drug Discovery, Urology
Gorlin Syndrome (Oncology) - Drugs In Development, 2021
Topics: Drug Discovery, Oncology/Hematology
Osteogenesis Imperfecta (Genitourinary Disorders) - Drugs In Development, 2021
Topics: Drug Discovery, Urology
Primary Immune Deficiency (PID) (Genitourinary Disorders) - Drugs In Development, 2021
Topics: Drug Discovery
Granulomatosis with Polyangiitis (Immunology) - Drugs In Development, 2021
Topics: Drug Discovery, Allergy/Immunology
Gonorrhea (Infectious Disease) - Drugs In Development, 2021
Topics: AIDS, HIV & STDs, Drug Discovery
Osteomyelitis (Infectious Disease) - Drugs In Development, 2021
Topics: Drug Discovery
Myocardial Ischemia (Cardiovascular) - Drugs In Development, 2021
Topics: Drug Discovery, Cardiovascular
Encephalomyelitis (Central Nervous System) - Drugs In Development, 2021
Topics: Drug Discovery, CNS/Neurology
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021
Topics: Alzheimer's Disease, Drug Discovery, CNS/Neurology
Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) - Drugs In Development, 2021
Topics: Drug Discovery, CNS/Neurology
Burns (Dermatology) - Drugs In Development, 2021
Topics: Drug Discovery, Dermatology
Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021
Topics: Drug Discovery, Dermatology
Liver Cirrhosis (Gastrointestinal) - Drugs In Development, 2021
Topics: Drug Discovery, Gastrointestinal
Apoptosis Regulator BAX - Drugs In Development, 2021
Topics: Stem Cell, Drug Discovery
Human Cytomegalovirus Envelope Glycoprotein B (gB) - Drugs In Development, 2021
Topics: Drug Discovery
Iduronate 2 Sulfatase - Drugs In Development, 2021
Topics: Drug Discovery
Leukotriene A 4 Hydrolase - Drugs In Development, 2021
Topics: Drug Discovery
Caspase 7 - Drugs In Development, 2021
Topics: Drug Discovery
Cell Division Protein FtsZ (ftsz) - Drugs In Development, 2021
Topics: Drug Discovery
Exportin 1 - Drugs In Development, 2021
Topics: Drug Discovery
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Drugs In Development, 2021
Topics: Drug Discovery
Tyrosine Protein Kinase Mer - Drugs In Development, 2021
Topics: Drug Discovery
Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Drugs In Development, 2021
Topics: Drug Discovery
Aryl Hydrocarbon Receptor - Drugs In Development, 2021
Topics: Drug Discovery
Bromodomain Testis Specific Protein - Drugs In Development, 2021
Topics: Drug Discovery
5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021
Topics: Drug Discovery
Hepatitis C - Competitive Landscape in 2021
Topics: Hepatitis, Drug Discovery, Clinical Trial


Prev  | 20  | 21  | 22  | 23  | 24  | 25  | 26  | 27  | 28  | 29  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.